PTK2 and melanoma: Notably, inhibition of GSK-3 has been previously observed to enhance cell death in melanoma by potentiating P53 activity, and has been shown to reduce invasive activity by modulating the function of N-cadherin and focal adhesion kinase (encoded by FAK) [25,26].